Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling
Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Yusuke Sakai, Noriyo Nagata, Takeshi Arashiro, Akira Ainai, Saya Moriyama, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Shuetsu Fukushi, Yoshimasa Takahashi, Ken Maeda, View ORCID ProfileTadaki Suzuki
doi: https://doi.org/10.1101/2023.02.08.23285673
Sho Miyamoto
aDepartment of Pathology, National Institute of Infectious Diseases; Tokyo, 162-8640, Japan
Yudai Kuroda
bDepartment of Veterinary Science, National Institute of Infectious Diseases; Tokyo 162-8640, Japan
Takayuki Kanno
aDepartment of Pathology, National Institute of Infectious Diseases; Tokyo, 162-8640, Japan
Akira Ueno
aDepartment of Pathology, National Institute of Infectious Diseases; Tokyo, 162-8640, Japan
Nozomi Shiwa-Sudo
aDepartment of Pathology, National Institute of Infectious Diseases; Tokyo, 162-8640, Japan
Naoko Iwata-Yoshikawa
aDepartment of Pathology, National Institute of Infectious Diseases; Tokyo, 162-8640, Japan
Yusuke Sakai
aDepartment of Pathology, National Institute of Infectious Diseases; Tokyo, 162-8640, Japan
Noriyo Nagata
aDepartment of Pathology, National Institute of Infectious Diseases; Tokyo, 162-8640, Japan
Takeshi Arashiro
aDepartment of Pathology, National Institute of Infectious Diseases; Tokyo, 162-8640, Japan
cCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, 162-8640, Tokyo, Japan
Akira Ainai
aDepartment of Pathology, National Institute of Infectious Diseases; Tokyo, 162-8640, Japan
Saya Moriyama
dResearch Center for Drug and Vaccine Development, National Institute of Infectious Diseases; Tokyo 162-8640, Japan
Noriko Kishida
eCenter for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases; Tokyo 208-0011, Japan
Shinji Watanabe
eCenter for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases; Tokyo 208-0011, Japan
Kiyoko Nojima
fDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases; 208-0011, Japan
Yohei Seki
fDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases; 208-0011, Japan
Takuo Mizukami
fDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases; 208-0011, Japan
Hideki Hasegawa
eCenter for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases; Tokyo 208-0011, Japan
Hideki Ebihara
gDepartment of Virology I, National Institute of Infectious Diseases; Tokyo 162-8640, Japan
Shuetsu Fukushi
gDepartment of Virology I, National Institute of Infectious Diseases; Tokyo 162-8640, Japan
Yoshimasa Takahashi
dResearch Center for Drug and Vaccine Development, National Institute of Infectious Diseases; Tokyo 162-8640, Japan
Ken Maeda
bDepartment of Veterinary Science, National Institute of Infectious Diseases; Tokyo 162-8640, Japan
Tadaki Suzuki
aDepartment of Pathology, National Institute of Infectious Diseases; Tokyo, 162-8640, Japan
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors. The code used to estimate the increase in NTs during the interval from the second vaccination to the third exposure are provided at the GitHub repository.
Posted February 10, 2023.
Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling
Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Yusuke Sakai, Noriyo Nagata, Takeshi Arashiro, Akira Ainai, Saya Moriyama, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Shuetsu Fukushi, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki
medRxiv 2023.02.08.23285673; doi: https://doi.org/10.1101/2023.02.08.23285673
Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling
Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Yusuke Sakai, Noriyo Nagata, Takeshi Arashiro, Akira Ainai, Saya Moriyama, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Shuetsu Fukushi, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki
medRxiv 2023.02.08.23285673; doi: https://doi.org/10.1101/2023.02.08.23285673
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (719)
- Anesthesia (214)
- Cardiovascular Medicine (3035)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12959)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4770)
- Geriatric Medicine (440)
- Health Economics (747)
- Health Informatics (3026)
- Health Policy (1095)
- Hematology (405)
- HIV/AIDS (951)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4544)
- Nursing (242)
- Nutrition (671)
- Oncology (2361)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (85)
- Pathology (512)
- Pediatrics (1229)
- Primary Care Research (515)
- Public and Global Health (7131)
- Radiology and Imaging (1586)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (503)
- Toxicology (63)
- Transplantation (218)
- Urology (187)